Toca

May 14, 2018

Tocagen to Present Preclinical Data on Anti-PD-L1 Product Candidate Toca 521 at the 2018 Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)

May 03, 2018

Tocagen to Report First Quarter 2018 Financial Results on Thursday, May 10

Apr 19, 2018

Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China Region

Mar 15, 2018

Tocagen to Present Preliminary Toca 6 Phase 1 Data and Immune Profiling Data at the American Association for Cancer Research (AACR) Annual Meeting 2018

Mar 08, 2018

Tocagen Reports Fourth Quarter and Full Year 2017 Financial and Business Results

Feb 07, 2018

Tocagen to Present at Leerink Partners 7th Annual Global Healthcare Conference

Nov 21, 2017

Tocagen Announces Time Change for Presentation at Evercore ISI Biopharma Catalyst/Deep Dive Conference

Nov 08, 2017

Tocagen Reports Third Quarter 2017 Financial and Business Results

Nov 01, 2017

Tocagen to Report Third Quarter 2017 Financial Results on Wednesday, November 8

Oct 17, 2017

Tocagen to Present Updated Durable Response Data from Phase 1 Trial of Toca 511 & Toca FC in Recurrent Brain Cancer at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Aug 09, 2017

Tocagen Reports Second Quarter 2017 Financial and Business Results

Aug 02, 2017

Tocagen to Report Second Quarter 2017 Financial Results on Wednesday, August 9